Skip to content
★ Sign in to follow
MJ

Michael J. McGinley

Heska Corp
Total declarations
88
Company
1
▲ Purchases (1 ops.)
€5,902
▼ Sales (52 ops.)
€3.2M

Latest filing published 27 Apr 2018 for HESKA CORP, €363k.

Filing timeline

BuySale
Michael J. McGinley

Insider track record

Disclosed buys
1
Disclosed sells
52
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Michael J. McGinley: trading record in brief

Michael J. McGinley is a declared insider of Heska Corp, with filings sourced from SEC (Form 4). The record holds 88 filings, for trades running from 25 February 2010 to 17 March 2018.

In open-market terms, that means 1 purchase worth €5,902 on one side and 52 sales worth €3.2M on the other. Netting one side against the other leaves €3.2M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 7 share grants and 28 option exercises.

The latest filing, published on 27 April 2018, reports a share grant of €363k in Heska Corp. The last insider purchase was made public on 26 February 2010, 6,099 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Michael J. McGinley

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations84 total
  • ◆
    Presi, Biologic. & Pharm.ExecutivesHeska Corp
    446,273 USD3SEC
    5,685 shares@ US$78.508.8% of flowCommon StockSEC:0001237648-18-000018:0
  • ▼
    Presi, Biologic. & Pharm.ExecutivesHeska Corp
    559,130 USD3SEC
    6,500 shares@ US$86.0211.5% of flowCommon StockSEC:0001237648-17-000071:0
  • ▼
    Presi, Biologic. & Pharm.ExecutivesHeska Corp
    89 USD2SEC
    1 shares@ US$88.540.0% of flowCommon StockSEC:0001237648-17-000068:0
  • ▼
    Presi, Biologic. & Pharm.ExecutivesHeska Corp
    70,552 USD2SEC
    800 shares@ US$88.191.4% of flowCommon StockSEC:0001237648-17-000068:1
  • ▼
    Presi, Biologic. & Pharm.ExecutivesHeska Corp
    611,316 USD3SEC
    7,025 shares@ US$87.0212.5% of flowCommon StockSEC:0001237648-17-000068:2
  • ▼
    Presi, Biologic. & Pharm.ExecutivesHeska Corp
    596,993 USD21SEC
    6,059 shares@ US$98.5312.9% of flowCommon StockSEC:0001237648-17-000055:0
  • ▼
    Presi, Biologic. & Pharm.ExecutivesHeska Corp
    505,459 USD21SEC
    5,130 shares@ US$98.5310.9% of flowCommon StockSEC:0001237648-17-000055:1
  • ◆
    Presi, Biologic. & Pharm.ExecutivesHeska Corp
    63,018 USD2SEC
    778 shares@ US$81.001.5% of flowCommon StockSEC:0001038133-17-000008:1
  • ◆
    Presi, Biologic. & Pharm.ExecutivesHeska Corp
    0SEC
    2,452 shares0Common StockSEC:0001038133-17-000008:0
  • ◇
    Pres., Biologic. & Pharm.ExecutivesHeska Corp
    17 USD22SEC
    1 shares@ US$17.170.0% of flowCommon StockSEC:0001038133-16-000326:0
  • ◇
    Presi, Biologic. & Pharm.ExecutivesHeska Corp
    16,154 USD2SEC
    891 shares@ US$18.130.4% of flowCommon StockSEC:0001038133-16-000324:0
  • ◇
    Presi, Biologic. & Pharm.ExecutivesHeska Corp
    115,940 USD2SEC
    2,916 shares@ US$39.762.6% of flowCommon StockSEC:0001038133-16-000324:1
  • ◇
    Presi, Biologic. & Pharm.ExecutivesHeska Corp
    92,117 USD2SEC
    5,365 shares@ US$17.172.1% of flowCommon StockSEC:0001038133-16-000324:2
  • ◇
    Presi, Biologic. & Pharm.ExecutivesHeska Corp
    128,100 USD2SEC
    7,000 shares@ US$18.302.9% of flowCommon StockSEC:0001038133-16-000324:3
  • ◇
    Presi, Biologic. & Pharm.ExecutivesHeska Corp
    42,000 USD2SEC
    3,000 shares@ US$14.000.9% of flowCommon StockSEC:0001038133-16-000324:4
  • ◇
    Presi, Biologic. & Pharm.ExecutivesHeska Corp
    63,000 USD2SEC
    14,000 shares@ US$4.501.4% of flowCommon StockSEC:0001038133-16-000324:5
  • ◇
    Presi, Biologic. & Pharm.ExecutivesHeska Corp
    66,960 USD2SEC
    13,500 shares@ US$4.961.5% of flowCommon StockSEC:0001038133-16-000324:6
  • ◇
    Presi, Biologic. & Pharm.ExecutivesHeska Corp
    103,500 USD2SEC
    15,000 shares@ US$6.902.3% of flowCommon StockSEC:0001038133-16-000324:7
  • ◇
    Presi, Biologic. & Pharm.ExecutivesHeska Corp
    122,906 USD2SEC
    14,375 shares@ US$8.552.7% of flowCommon StockSEC:0001038133-16-000324:8
  • ◇
    Presi, Biologic. & Pharm.ExecutivesHeska Corp
    95,842 USD2SEC
    13,022 shares@ US$7.362.1% of flowCommon StockSEC:0001038133-16-000324:9
  • ◇
    Presi, Biologic. & Pharm.ExecutivesHeska Corp
    22,999 USD2SEC
    5,227 shares@ US$4.400.5% of flowCommon StockSEC:0001038133-16-000324:10
  • ◇
    Presi, Biologic. & Pharm.ExecutivesHeska Corp
    31,184 USD2SEC
    1,720 shares@ US$18.130.7% of flowCommon StockSEC:0001038133-16-000324:11
  • ▼
    Presi, Biologic. & Pharm.ExecutivesHeska Corp
    63,854 USD14SEC
    1,063 shares@ US$60.071.4% of flowCommon StockSEC:0001038133-16-000319:0
  • ▼
    Presi, Biologic. & Pharm.ExecutivesHeska Corp
    1,495 USD14SEC
    25 shares@ US$59.810.0% of flowCommon StockSEC:0001038133-16-000319:1
  • ▼
    Presi, Biologic. & Pharm.ExecutivesHeska Corp
    64,541 USD14SEC
    1,080 shares@ US$59.761.4% of flowCommon StockSEC:0001038133-16-000319:2

25 of 84 declarations